XML 198 R129.htm IDEA: XBRL DOCUMENT v2.4.0.8
EQUITY (Details 2) (USD $)
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended
Dec. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Jan. 14, 2011
Dec. 31, 2011
Common Stock Issued
Dec. 31, 2013
Common Stock Issued
Dec. 31, 2012
Common Stock Issued
Dec. 31, 2010
Common Stock Issued
Dec. 31, 2011
Preferred Stock
Dec. 31, 2011
Additional Paid-in Capital
Dec. 31, 2011
Series E
Preferred Stock
Dec. 31, 2010
Series E
Preferred Stock
Dec. 31, 2011
Series F
Preferred Stock
Dec. 31, 2010
Series F
Preferred Stock
Dec. 31, 2011
Series C
Preferred Stock
Dec. 31, 2010
Series C
Preferred Stock
Jan. 14, 2011
Recapitalization
Jan. 14, 2011
Recapitalization
Common Stock Issued
Jan. 14, 2011
Recapitalization
Additional Paid-in Capital
Jan. 14, 2011
Recapitalization
Retained Earnings (Accumulated Deficit)
Jan. 14, 2011
Recapitalization
Noncontrolling nonvoting, callable, junior and senior preferred interests held by Federal Reserve Bank of New York
Dec. 31, 2013
Recapitalization
Series E
Preferred Stock
Jan. 14, 2011
Recapitalization
Series E
Preferred Stock
Jan. 14, 2011
Recapitalization
Series F
Preferred Stock
Dec. 31, 2013
Recapitalization
Series C
Preferred Stock
Jan. 14, 2011
Recapitalization
Series C
Preferred Stock
Dec. 31, 2013
Recapitalization
Series G
Preferred Stock
Jan. 31, 2011
Recapitalization
Series G
Preferred Stock
Jan. 14, 2011
Recapitalization
Other assets
Jan. 14, 2011
Recapitalization
Other liabilities
Jan. 14, 2011
Recapitalization
Federal Reserve Bank of New York credit facility
Jan. 14, 2011
Recapitalization
Redeemable noncontrolling nonvoting, callable, junior preferred interests held by Department of Treasury
Effect of Recapitalization                                                                
Preferred stock, par value (in dollars per share)                                           $ 5.00     $ 5.00   $ 5.00          
Repayment and Termination of FRBNY Credit Facility       $ (21,000,000,000)                                                     $ (20,689,000,000)  
Repayment and Termination of FRBNY Credit Facility, including recognition of deferred gain                                                           (325,000,000)    
Repayment and Termination of FRBNY Credit Facility, including write-off of prepaid commitment fee                                                         (24,297,000,000)      
Repayment and Termination of FRBNY Credit Facility, amortization of prepaid commitment fees (3,300,000,000)                                     (3,283,000,000)                        
Repurchase and Exchange of SPV Preferred interests                                                         (6,140,000,000)      
Repurchase and Exchange of SPV Preferred interests 20,677,000,000       (4,138,000,000)         (67,460,000,000)                                           20,292,000,000
Repayment of FRBNY SPV Preferred Interests (26,432,000,000) [1]                                       (26,432,000,000)                      
Exchange of Preferred Stock for Common Stock Value                 (71,983,000,000)   (41,605,000,000)   (7,378,000,000)   (23,000,000,000)     4,138,000,000 67,845,000,000                          
Total Effect of Recapitalization                                   4,138,000,000 67,845,000,000 (3,283,000,000) (26,432,000,000)   (41,605,000,000) (7,378,000,000)   (23,000,000,000)     (30,437,000,000) (325,000,000) (20,689,000,000) 20,292,000,000
Exchange of Preferred Stock for Common Stock shares                                 1,655,037,962                              
Total Effect of Recapitalization Common Stock shares outstanding   1,906,645,689 1,906,611,680   1,906,568,099 1,906,645,689 1,906,611,680 147,124,067                 1,655,037,962                              
Preferred stock, shares issued                       400,000   300,000   100,000                       20,000        
Preferred stock, aggregate liquidation value                                                       $ 0        
[1] See Notes 17 and 24 to Consolidated Financial Statements.